These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 16931203

  • 1. Clinical benefits of a metabolic approach in the cardiac rehabilitation of patients with coronary artery disease.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Am J Cardiol; 2006 Sep 04; 98(5A):25J-33J. PubMed ID: 16931203
    [Abstract] [Full Text] [Related]

  • 2. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 04; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 3. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun 04; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 4. Role of trimetazidine in management of ischemic cardiomyopathy.
    Bertomeu-Gonzalez V, Bouzas-Mosquera A, Kaski JC.
    Am J Cardiol; 2006 Sep 04; 98(5A):19J-24J. PubMed ID: 16931202
    [Abstract] [Full Text] [Related]

  • 5. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R.
    Rev Port Cardiol; 2000 Nov 04; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [Abstract] [Full Text] [Related]

  • 6. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
    Rosano GM, Vitale C, Fragasso G.
    Am J Cardiol; 2006 Sep 04; 98(5A):14J-18J. PubMed ID: 16931201
    [Abstract] [Full Text] [Related]

  • 7. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 8. Clinical benefits of a metabolic approach in the management of coronary patients.
    Marzilli M.
    Rev Port Cardiol; 2000 Nov 05; 19 Suppl 5():V25-30. PubMed ID: 11206100
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical benefits of trimetazidine in patients with recurrent angina.
    Szwed H.
    Coron Artery Dis; 2004 May 05; 15 Suppl 1():S17-21. PubMed ID: 15179124
    [Abstract] [Full Text] [Related]

  • 12. [Ischemic heart disease and left ventricular dysfunction: the role of trimetazidine].
    Belardinelli R.
    Ital Heart J; 2004 Mar 05; 5 Suppl 2():23S-28S. PubMed ID: 15074774
    [Abstract] [Full Text] [Related]

  • 13. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV).
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep 05; 33(9):793-5. PubMed ID: 16266453
    [Abstract] [Full Text] [Related]

  • 14. Regulation of coronary blood flow during exercise.
    Duncker DJ, Bache RJ.
    Physiol Rev; 2008 Jul 05; 88(3):1009-86. PubMed ID: 18626066
    [Abstract] [Full Text] [Related]

  • 15. Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina.
    Danchin N.
    Am J Cardiol; 2006 Sep 04; 98(5A):8J-13J. PubMed ID: 16931200
    [Abstract] [Full Text] [Related]

  • 16. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.
    Rosano GM, Vitale C, Sposato B, Mercuro G, Fini M.
    Cardiovasc Diabetol; 2003 Nov 28; 2():16. PubMed ID: 14641923
    [Abstract] [Full Text] [Related]

  • 17. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov 28; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.